Treatment of patients with hepatitis C and cirrhosis.

PubWeight™: 1.02‹?› | Rank: Top 15%

🔗 View Article (PMID 12407593)

Published in Hepatology on November 01, 2002


Teresa L Wright1

Author Affiliations

1: Gastroenterology Section, Veterans Affairs Medical Center, University of California, San Francisco, USA.

Articles citing this

De novo hepatocellular carcinoma occurring in a transplanted liver: case report and review of the literature. Dig Dis Sci (2006) 1.45

Peginterferon alfa-2a (40KD) plus ribavirin in chronic hepatitis C patients who failed previous interferon therapy. Gut (2006) 1.22

Cost-effectiveness of sofosbuvir in the treatment of patients with hepatitis C. J Viral Hepat (2014) 1.16

High Sustained Virologic Response to Daclatasvir Plus Asunaprevir in Elderly and Cirrhotic Patients with Hepatitis C Virus Genotype 1b Without Baseline NS5A Polymorphisms. Adv Ther (2015) 1.06

Impaired expression of type I and type II interferon receptors in HCV-associated chronic liver disease and liver cirrhosis. PLoS One (2014) 0.89

Treatment of hepatitis C virus infection. World J Gastroenterol (2007) 0.87

Severe adverse events during antiviral therapy in hepatitis C virus cirrhotic patients: A systematic review. World J Hepatol (2013) 0.85

Strategies to reduce hepatitis C virus recurrence after liver transplantation. World J Hepatol (2013) 0.82

Prognostic factors for progression of liver structural lesions in chronic hepatitis C patients. World J Gastroenterol (2008) 0.79

Improved hepatitis C treatment response in younger patients: findings from the UK HCV National Register cohort study. Epidemiol Infect (2011) 0.76

Economic study of the value of expanding HCV treatment capacity in Germany. BMJ Open Gastroenterol (2017) 0.75

Interleukin-28B gene non-TT allele strongly predicts treatment failure for genotype 1 infected chronic hepatitis C patients with advanced fibrosis: a case control study. BMC Infect Dis (2015) 0.75

Predictors for dose reduction of antiviral therapy in older patients infected with hepatitis C virus: a meta-regression analysis. Eur J Clin Microbiol Infect Dis (2013) 0.75